Cargando…

Eribulin Approval in Advanced Liposarcoma – Successful Drug or a Weaker Methodology?

Detalles Bibliográficos
Autores principales:	Rastogi, Sameer, Gupta, Vineet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398101/ https://www.ncbi.nlm.nih.gov/pubmed/28469328 http://dx.doi.org/10.4103/0971-5851.203492

Ejemplares similares

Why make a strong muscle weaker?
por: Iorga, Bogdan, et al.
Publicado: (2021)

Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma
por: Tamiya, Hironari, et al.
Publicado: (2020)

Eribulin in Patients with Liposarcoma and Leiomyosarcoma: A Retrospective Single-Center Experience
por: Steinbrecher, Oskar, et al.
Publicado: (2023)

Eribulin drug review
por: Shetty, Nishitha, et al.
Publicado: (2014)

COVID-19: Is there a weaker sex?
por: Gómez-Ochoa, Sergio Alejandro, et al.
Publicado: (2020)

Eribulin for Advanced Breast Cancer: A Drug Evaluation
por: Shablak, Alaaeldin
Publicado: (2013)

Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and Implications of New Biomarkers
por: Nakamura, Hajime, et al.
Publicado: (2022)

Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and the Implications of New Biomarkers
por: Schöffski, Patrick
Publicado: (2022)

Weaker is better
por: Nyberg, Kara A.
Publicado: (2005)

The Weaker Sex
por: Hess, Sharon Folkenroth
Publicado: (2022)

Weaker together or weaker apart? Great power relations after the coronavirus
por: Biscop, Sven
Publicado: (2020)

Our Weaker Brethren
Publicado: (1893)

Keynote-158 study, FDA granted accelerated approval of pembrolizumab for the treatment of patients with advanced PD-L1-positive cervical cancer
por: Borcoman, Edith, et al.
Publicado: (2020)

Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide Drugs
por: Stein, Cy, et al.
Publicado: (2016)

Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma
por: Chen, Mark, et al.
Publicado: (2019)

Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies
por: Blumenthal, Gideon M., et al.
Publicado: (2017)

Time for the US food and drug administration approval of condoms for anal intercourse
por: Nguyen, Brian T., et al.
Publicado: (2019)

On weaker forces than gravity
por: De Rújula, Alvaro
Publicado: (1986)

Weaker neural suppression in autism
por: Schallmo, Michael-Paul, et al.
Publicado: (2020)

The Current State of Pharma and the FDA: Approval of a Dementia Drug as a Case in Point
por: Eiser, Arnold R.
Publicado: (2021)

Can an FDA-Approved Alzheimer’s Drug Be Repurposed for Alleviating Neuronal Symptoms of Zika Virus?
por: Sirohi, Devika, et al.
Publicado: (2017)

Advances in the treatment of soft tissue sarcoma: focus on eribulin
por: Koliou, Panagiotis, et al.
Publicado: (2018)

Scoping reviews: reinforcing and advancing the methodology and application
por: Peters, Micah D. J., et al.
Publicado: (2021)

Case Marking in Hindi as the Weaker Language
por: Montrul, Silvina, et al.
Publicado: (2019)

The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV
por: Rojo, Pablo, et al.
Publicado: (2020)

Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
por: Steinberg, Judith, et al.
Publicado: (2019)

Potential targeted therapeutic approaches in liposarcoma
por: Kanojia, Deepika, et al.
Publicado: (2016)

Eribulin in Cancer Treatment
por: Swami, Umang, et al.
Publicado: (2015)

Novel targeted drugs approved by the NMPA and FDA in 2019
por: Wang, Wenjing, et al.
Publicado: (2020)

Flibanserin: Approval of a controversial drug for a controversial disorder
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2015)

Efficacy and safety of eribulin mesylate in advanced soft tissue sarcomas
por: Noujaim, Jonathan, et al.
Publicado: (2016)

Weaker Dental Enamel Explains Dental Decay
por: Vieira, Alexandre R., et al.
Publicado: (2015)

Weaker Self-Esteem in Adolescence Predicts Smoking
por: Saari, Antti J., et al.
Publicado: (2015)

Prucalopride: A Recently Approved Drug by the Food and Drug Administration for Chronic Idiopathic Constipation
por: Mahajan, Rajiv
Publicado: (2019)

Bedaquiline: First FDA-approved tuberculosis drug in 40 years
por: Mahajan, Rajiv
Publicado: (2013)

Repurposing of FDA-approved drugs against cancer – focus on metastasis
por: Ozsvári, Béla, et al.
Publicado: (2016)

Prescription Drugs Marketed in the United States Should Be Approved by the FDA
por: Shepherd, Marvin
Publicado: (2003)

Single-arm trials for domestic oncology drug approvals in China
por: Zhang, Hong, et al.
Publicado: (2023)

Advances in the targeted therapy of liposarcoma
por: Guan, Zhonghai, et al.
Publicado: (2015)

Recent advances in the management of liposarcoma
por: Nassif, Nadar A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fui68g90iivp53m29iqq1ts213